The HLT Meridian TAVR Valve System is designed to overcome some of the challenges of current FDA-cleared TAVR devices.
This “hyperinvasive” approach performed better than expected outcomes also seen in patients who received standard advanced cardiac life support.
The Consumer Technology Association (CTA) is collaborating with the American College of Cardiology (ACC) and several vendors on best practices for device and app and wearable device makers to provide deeper understanding of products that manage cardiovascular health.
Today, as TAVR now makes up more procedural volume in the U.S. than surgical aortic replacements, many hospitals that have not already created a structural heart program are now looking at creating one.
National Heart, Lung, and Blood Institute (NHLBI) has awarded a grant of $462,689 to Rhythm Therapeutics Inc. (RTI) to complete the phase 1 segment of the development of a novel gene therapy to treat atrial fibrillation (AF). It involves using electroporation to create temporary openings in cardiac cells to deliver therapeutic transgenes targeting the underlying […]
Elixir Medical recently announced the first patient was treated in the BIOADAPTOR randomized controlled trial (RCT) of the DynamX Coronary Bioadaptor System, the first drug-eluting coronary stent that adapts to vessel physiology.
Class I recall includes Evera, Viva, Brava, Claria, Amplia, Compia and Visia implantable cardioverter defibrillators and cardiac resynchronization therapy devices.
In the early 2000s, the cardiology department at WHS Washington Hospital needed to replace an outdated paper reporting system with a modern system that could streamline workflows, reduce redundant data entry, and balance workloads.
New RVOT repair device provides less invasive option to treat pulmonary valve regurgitation for patients with a native or surgically-repaired right ventricular outflow tract.
While many cardiac and vascular procedures have largely moved to minimally invasive techniques, the size of these transcatheter devices has required larger arterial access introducer sheaths, leading to increases in vascular and bleeding complications. Large bore devices are generally considered anything 10 French and bigger. This growth in large bore interventions has led to a […]
Stay Up-To-Date on jobs and industry news.
Sign up for the CathLab.com newsletter today!